Marja Puurunen

An engineered <i>E. coli</i> Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

Caroline Kurtz, Yves Millet, Marja Puurunen et al. · Science Translational Medicine · 2019 · 392 citations

Life Sciences, Biological Engineering, Biotechnology +12

Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men

Outi Vaarala, Matti Mänttäri, Vesa Manninen et al. · Circulation · 1995 · 312 citations

Medicine, Immunology, Internal Medicine +16

Antibody Against Oxidized Low-Density Lipoprotein Predicting Myocardial Infarction

Marja Puurunen · Archives of Internal Medicine · 1994 · 291 citations

Medicine, Cardiology, Immunology +14

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Sara Lindström, Lu Wang, Erin N. Smith et al. · Blood · 2019 · 236 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study

Marja Puurunen, Jerry Vockley, Shawn Searle et al. · Nature Metabolism · 2021 · 160 citations

Engineering, Biological Engineering, Biotechnology +5